158 related articles for article (PubMed ID: 7543549)
1. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent.
Amagai M; Ishii K; Hashimoto T; Gamou S; Shimizu N; Nishikawa T
J Invest Dermatol; 1995 Aug; 105(2):243-7. PubMed ID: 7543549
[TBL] [Abstract][Full Text] [Related]
2. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus.
Amagai M; Hashimoto T; Green KJ; Shimizu N; Nishikawa T
J Invest Dermatol; 1995 Jun; 104(6):895-901. PubMed ID: 7539469
[TBL] [Abstract][Full Text] [Related]
4. Transport to endoplasmic reticulum by signal peptide, but not proteolytic processing, is required for formation of conformational epitopes of pemphigus vulgaris antigen (Dsg3).
Amagai M; Ishii K; Takayanagi A; Nishikawa T; Shimizu N
J Invest Dermatol; 1996 Oct; 107(4):539-42. PubMed ID: 8823357
[TBL] [Abstract][Full Text] [Related]
5. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
[TBL] [Abstract][Full Text] [Related]
7. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.
Sekiguchi M; Futei Y; Fujii Y; Iwasaki T; Nishikawa T; Amagai M
J Immunol; 2001 Nov; 167(9):5439-48. PubMed ID: 11673563
[TBL] [Abstract][Full Text] [Related]
8. Pemphigus sera recognize conformationally sensitive epitopes in the amino-terminal region of desmoglein-1.
Kowalczyk AP; Anderson JE; Borgwardt JE; Hashimoto T; Stanley JR; Green KJ
J Invest Dermatol; 1995 Aug; 105(2):147-52. PubMed ID: 7543545
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity against intracellular domains of desmogleins in pemphigus.
Ohata Y; Amagai M; Ishii K; Hashimoto T
J Dermatol Sci; 2001 Jan; 25(1):64-71. PubMed ID: 11154866
[TBL] [Abstract][Full Text] [Related]
10. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients.
Amagai M; Koch PJ; Nishikawa T; Stanley JR
J Invest Dermatol; 1996 Feb; 106(2):351-5. PubMed ID: 8601740
[TBL] [Abstract][Full Text] [Related]
11. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
Hacker MK; Janson M; Fairley JA; Lin MS
Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995
[TBL] [Abstract][Full Text] [Related]
12. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
13. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
[TBL] [Abstract][Full Text] [Related]
14. A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins.
Hashimoto T; Amagai M; Watanabe K; Dmochowski M; Chidgey MA; Yue KK; Garrod DR; Nishikawa T
J Invest Dermatol; 1995 Apr; 104(4):541-4. PubMed ID: 7706774
[TBL] [Abstract][Full Text] [Related]
15. Differences in the expression of pemphigus antigens during epidermal differentiation.
Iwatsuki K; Harada H; Yokote R; Kaneko F
Br J Dermatol; 1995 Aug; 133(2):209-16. PubMed ID: 7547386
[TBL] [Abstract][Full Text] [Related]
16. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
[TBL] [Abstract][Full Text] [Related]
17. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.
Adams MJ; Reichel MB; King IA; Marsden MD; Greenwood MD; Thirlwell H; Arnemann J; Buxton RS; Ali RR
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):165-74. PubMed ID: 9405290
[TBL] [Abstract][Full Text] [Related]
20. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
Kamiya K; Aoyama Y; Yamasaki O; Kamata A; Yamagami J; Iwatsuki K; Tokura Y
Br J Dermatol; 2016 Jan; 174(1):113-9. PubMed ID: 26294113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
